Matthew Ross Boyd
Chief Regulatory Officer, enGene Therapeutics Inc.
Companies
- enGene Therapeutics Inc.Chief Regulatory Officer Jul 14, 2025 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- enGene Therapeutics Inc. ENGN7,500 shares2$12.5K at $1.67Jul 14, 2025
As of each latest filing. The line shows shares held over time.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2